Cardiovasc Prev Pharmacother > v.2(3)

5 results

63 Prevention of Type 2 Diabetes
Jong Dai Kim, Won-Young Lee
KMSID: 1516079353   Cardiovasc Prev Pharmacother. 2020;2(3):63-76.   Published online 2020 July 31    DOI: http://dx.doi.org/10.36011/cpp.2020.2.e10
      
77 Competing Risk Model in Survival Analysis
Yena Jeon, Won Kee Lee
KMSID: 1516079355   Cardiovasc Prev Pharmacother. 2020;2(3):77-84.   Published online 2020 July 31    DOI: http://dx.doi.org/10.36011/cpp.2020.2.e11
      
85 Pragmatic Clinical Trials for Real-World Evidence: Concept and Implementation
Na-Young Jeong, Seon-Ha Kim, Eunsun Lim, Nam-Kyong Choi
KMSID: 1516079356   Cardiovasc Prev Pharmacother. 2020;2(3):85-98.   Published online 2020 July 31    DOI: http://dx.doi.org/10.36011/cpp.2020.2.e12
      
99 Causal Claims in Health Sciences and Medicine: a Difference-in-Differences Method
Kyoung-Nam Kim
KMSID: 1516079357   Cardiovasc Prev Pharmacother. 2020;2(3):99-102.   Published online 2020 July 31    DOI: http://dx.doi.org/10.36011/cpp.2020.2.e13
      
103 Changes in Target Achievement Rates after Statin Prescription Changes at a Single University Hospital
Seon Choe, Jiwon Shinn, Hun-Sung Kim, Ju Han Kim
KMSID: 1516079358   Cardiovasc Prev Pharmacother. 2020;2(3):103-111.   Published online 2020 July 31    DOI: http://dx.doi.org/10.36011/cpp.2020.2.e14
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap